SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-14-009466
Filing Date
2014-02-14
Accepted
2014-02-14 14:11:13
Documents
2
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13G v368565_sc13g.htm SC 13G 81082
2 EXHIBIT 99.1 v368565_ex99-1.htm EX-99.1 6005
  Complete submission text file 0001144204-14-009466.txt   88836
Mailing Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81457 | Film No.: 14614560
SIC: 2836 Biological Products, (No Diagnostic Substances)